Home > Research > Publications & Outputs > Predicted Impact of COVID-19 on Neglected Tropi...

Research

Associated organisational unit

Links

Text available via DOI:

Keywords

View graph of relations

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. / Toor, Jaspreet; Adams, Emily R.; Aliee, Maryam et al.
In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, No. 8, 15.04.2021, p. 1463-1466.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Toor, J, Adams, ER, Aliee, M, Amoah, B, Anderson, RM, Ayabina, D, Bailey, R, Basáñez, MG, Blok, DJ, Blumberg, S, Borlase, A, Rivera, RC, Castaño, MS, Chitnis, N, Coffeng, LE, Crump, RE, Das, A, Davis, CN, Davis, EL, Deiner, MS, Diggle, PJ, Fronterre, C, Giardina, F, Giorgi, E, Graham, M, Hamley, JID, Huang, CI, Kura, K, Lietman, TM, Lucas, TCD, Malizia, V, Medley, GF, Meeyai, A, Michael, E, Porco, TC, Prada, JM, Rock, KS, Le Rutte, EA, Smith, ME, Spencer, SEF, Stolk, WA, Touloupou, P, Vasconcelos, A, Vegvari, C, de Vlas, SJ, Walker, M & Hollingsworth, TD 2021, 'Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 72, no. 8, pp. 1463-1466. https://doi.org/10.1093/cid/ciaa933

APA

Toor, J., Adams, E. R., Aliee, M., Amoah, B., Anderson, R. M., Ayabina, D., Bailey, R., Basáñez, M. G., Blok, D. J., Blumberg, S., Borlase, A., Rivera, R. C., Castaño, M. S., Chitnis, N., Coffeng, L. E., Crump, R. E., Das, A., Davis, C. N., Davis, E. L., ... Hollingsworth, T. D. (2021). Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(8), 1463-1466. https://doi.org/10.1093/cid/ciaa933

Vancouver

Toor J, Adams ER, Aliee M, Amoah B, Anderson RM, Ayabina D et al. Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Apr 15;72(8):1463-1466. Epub 2020 Sept 28. doi: 10.1093/cid/ciaa933

Author

Toor, Jaspreet ; Adams, Emily R. ; Aliee, Maryam et al. / Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 ; Vol. 72, No. 8. pp. 1463-1466.

Bibtex

@article{6362b9027bdc46a2a1de925997c72932,
title = "Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation",
abstract = "Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.",
keywords = "coronavirus, modeling, neglected tropical diseases",
author = "Jaspreet Toor and Adams, {Emily R.} and Maryam Aliee and Benjamin Amoah and Anderson, {Roy M.} and Diepreye Ayabina and Robin Bailey and Bas{\'a}{\~n}ez, {Maria Gloria} and Blok, {David J.} and Seth Blumberg and Anna Borlase and Rivera, {Rocio Caja} and Casta{\~n}o, {Mar{\'i}a Soledad} and Nakul Chitnis and Coffeng, {Luc E.} and Crump, {Ronald E.} and Aatreyee Das and Davis, {Christopher N.} and Davis, {Emma L.} and Deiner, {Michael S.} and Diggle, {Peter J.} and Claudio Fronterre and Federica Giardina and Emanuele Giorgi and Matthew Graham and Hamley, {Jonathan I.D.} and Huang, {Ching I.} and Klodeta Kura and Lietman, {Thomas M.} and Lucas, {Tim C.D.} and Veronica Malizia and Medley, {Graham F.} and Aronrag Meeyai and Edwin Michael and Porco, {Travis C.} and Prada, {Joaquin M.} and Rock, {Kat S.} and {Le Rutte}, {Epke A.} and Smith, {Morgan E.} and Spencer, {Simon E.F.} and Stolk, {Wilma A.} and Panayiota Touloupou and Andreia Vasconcelos and Carolin Vegvari and {de Vlas}, {Sake J.} and Martin Walker and Hollingsworth, {T. D{\'e}irdre}",
year = "2021",
month = apr,
day = "15",
doi = "10.1093/cid/ciaa933",
language = "English",
volume = "72",
pages = "1463--1466",
journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
issn = "1058-4838",
publisher = "BioMed Central",
number = "8",

}

RIS

TY - JOUR

T1 - Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

AU - Toor, Jaspreet

AU - Adams, Emily R.

AU - Aliee, Maryam

AU - Amoah, Benjamin

AU - Anderson, Roy M.

AU - Ayabina, Diepreye

AU - Bailey, Robin

AU - Basáñez, Maria Gloria

AU - Blok, David J.

AU - Blumberg, Seth

AU - Borlase, Anna

AU - Rivera, Rocio Caja

AU - Castaño, María Soledad

AU - Chitnis, Nakul

AU - Coffeng, Luc E.

AU - Crump, Ronald E.

AU - Das, Aatreyee

AU - Davis, Christopher N.

AU - Davis, Emma L.

AU - Deiner, Michael S.

AU - Diggle, Peter J.

AU - Fronterre, Claudio

AU - Giardina, Federica

AU - Giorgi, Emanuele

AU - Graham, Matthew

AU - Hamley, Jonathan I.D.

AU - Huang, Ching I.

AU - Kura, Klodeta

AU - Lietman, Thomas M.

AU - Lucas, Tim C.D.

AU - Malizia, Veronica

AU - Medley, Graham F.

AU - Meeyai, Aronrag

AU - Michael, Edwin

AU - Porco, Travis C.

AU - Prada, Joaquin M.

AU - Rock, Kat S.

AU - Le Rutte, Epke A.

AU - Smith, Morgan E.

AU - Spencer, Simon E.F.

AU - Stolk, Wilma A.

AU - Touloupou, Panayiota

AU - Vasconcelos, Andreia

AU - Vegvari, Carolin

AU - de Vlas, Sake J.

AU - Walker, Martin

AU - Hollingsworth, T. Déirdre

PY - 2021/4/15

Y1 - 2021/4/15

N2 - Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.

AB - Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.

KW - coronavirus

KW - modeling

KW - neglected tropical diseases

U2 - 10.1093/cid/ciaa933

DO - 10.1093/cid/ciaa933

M3 - Journal article

C2 - 32984870

AN - SCOPUS:85098735477

VL - 72

SP - 1463

EP - 1466

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

SN - 1058-4838

IS - 8

ER -